Ergoteles LLC West Pharmaceutical Services Inc Transaction History

Ergoteles LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$209.34 - $261.61 $636,184 - $795,032	-3,039 Reduced 42.99%	4,030 $948,000
Q3 2022 Nov 14, 2022	BUY	$246.08 - $343.65 $1.16 Million - $1.62 Million	4,723 Added 201.32%	7,069 $1.74 Million
Q2 2022 Aug 12, 2022	SELL	$280.61 - $420.45 $932,467 - $1.4 Million	-3,323 Reduced 58.62%	2,346 $709,000
Q1 2022 May 13, 2022	BUY	$357.49 - $445.92 $1.63 Million - $2.03 Million	4,548 Added 405.71%	5,669 $2.33 Million
Q4 2021 Feb 14, 2022	BUY	$402.25 - $471.34 $450,922 - $528,372	1,121 New	1,121 $526,000
Q3 2021 Nov 15, 2021	SELL	$363.01 - $468.47 $790,272 - $1.02 Million	-2,177 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$284.77 - $363.2 $2.77 Million - $3.53 Million	-9,723 Reduced 81.71%	2,177 $782,000
Q1 2021 May 12, 2021	SELL	$257.29 - $307.53 $15.9 Million - $19 Million	-61,700 Reduced 83.83%	11,900 $3.35 Million
Q4 2020 Feb 11, 2021	BUY	$261.16 - $301.66 $19.2 Million - $22.2 Million	73,600 New	73,600 $20.9 Million

803

64.4M

294K

490K

Ticker WST
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 74,033,000
Market Cap $24.7B
Description
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...

Get notified when there are updates to the investment portfolio of Ergoteles LLC, based on Form 13F filings with the SEC.

Stay updated on Ergoteles LLC with notifications on news.